Actinium Pharmaceuticals reported $-5.13M in Pre-Tax Profit for its fiscal quarter ending in September of 2025.





Pre Tax Profit Change Date
AbbVie USD 7.61B 2.04B Jun/2026
Actinium Pharmaceuticals USD -5.13M 1.75M Sep/2025
Amgen USD 2.08B 570M Mar/2026
Bioline Rx USD -2.59M 352K Mar/2026
Capricor Therapeutics USD -30.17M 5.6M Dec/2025
Pfizer USD -653M 5.84B Jun/2026